Weijun Cheng
About Weijun Cheng
Weijun Cheng is the Associate Director of Product Development at ANI Pharmaceuticals, Inc., where he has worked since 2020. He has extensive experience in the pharmaceutical industry, having previously held positions at Arrowhead Pharmaceuticals and ANI Pharmaceuticals, and holds a Ph.D. in Physiology from the University of Wisconsin-Madison.
Work at ANI Pharmaceuticals
Weijun Cheng has been serving as the Associate Director of Product Development at ANI Pharmaceuticals, Inc. since 2020. In this role, he is responsible for overseeing the preparation of Chemistry, Manufacturing, and Controls (CMC) documents to support regulatory filings for injectable drugs. His position involves managing API and drug product manufacturing activities, with a focus on process improvements and root cause analysis. Prior to this role, he worked as a Senior Development Scientist at ANI Pharmaceuticals from 2017 to 2020.
Previous Experience at Arrowhead Pharmaceuticals
Weijun Cheng worked at Arrowhead Pharmaceuticals for a total of eleven years. He began his tenure there as a Postdoctoral Scientist from 2005 to 2006, before transitioning to a Senior Scientist role from 2007 to 2017. During his time at Arrowhead, he contributed to various projects and initiatives within the pharmaceutical development sector, leveraging his expertise in drug development.
Education and Expertise
Weijun Cheng holds a Bachelor of Science degree in Biology from Fudan University. He furthered his education at the University of Wisconsin-Madison, where he earned a Ph.D. in Physiology. His academic background provides a solid foundation for his work in product development and regulatory compliance in the pharmaceutical industry.
Background
Weijun Cheng has built a career in the pharmaceutical industry, with a focus on product development and regulatory processes. He has extensive experience in preparing CMC documents and overseeing manufacturing activities. His work emphasizes process improvements and addressing root causes in drug development, contributing to the efficiency and effectiveness of pharmaceutical production.